THC BIOMED INTL LTD ORD - THCBF STOCK NEWS

THC BioMed Intl Ltd. (THCBF) has announced a successful re-order of its THC KISS Cannabis Biscuits from a Saskatchewan distributor. These edibles contain 10 mg of a proprietary, fast-acting THC extract developed by the company. Available in three flavors—Shortbread, Cocoa, and Cinnamon—the biscuits represent THC BioMed's latest product offering. This re-order signals positive market reception and potential for increased sales in the cannabis edibles segment.

THC BioMed Intl Ltd. has successfully shipped its THC Kiss Mango Beverage shot to Ontario Cannabis Stores. This milestone reflects the company's commitment to becoming a leader in the cannabis beverage and edible market. Established in 2013, THC BioMed is one of Canada's oldest licensed cannabis producers and is focused on scientific research and product development in this growing industry. The company holds licenses for various cannabis products and aims to leverage its extensive experience to enhance its market position.

THC BioMed Intl Ltd. (THCBF) has successfully completed its inaugural shipment to Yukon Cannabis, which includes dried cannabis and cannabis cookies. This marks a significant milestone for the company as it continues to establish its presence in the Canadian cannabis market. THC BioMed is recognized as one of Canada’s oldest licensed cannabis producers under the Cannabis Act, operating within both medical and recreational sectors. This development could potentially enhance THC BioMed's market reach and revenue streams.

THC BioMed Intl Ltd announced an amendment to its Health Canada License, allowing the addition of three new strata units at its Acland Road facility. These units include a storage area for edibles and dedicated production rooms for edibles, such as baked goods. Founded in 2013, THC BioMed aims to lead the beverage and edible cannabis sector, being a licensed producer of various cannabis products including dried and topical forms. The company has emphasized its commitment to research and development in the rapidly growing cannabis market.

THC BioMed Intl Ltd. (THCBF) has engaged Oak Hill Financial to enhance its investor relations over a three-month term at a cost of $24,000 plus HST. Additionally, THC will issue 300,000 options to Oak Hill, priced at the higher of the closing price on the issuance date or the previous day. The partnership aims to improve THC's visibility in the financial community while the company continues expanding its product lines. As one of Canada's oldest licensed cannabis producers, THC BioMed focuses on medical and recreational markets.

THC BioMed Intl Ltd. (THCBF) has engaged a consultant for an enhancement project on its automated cannabis cylinder machine to boost production and add automated packaging. The consultant is granted 500,000 stock options, vesting over milestones such as restarting production and approval of cannabis cylinders. THC BioMed aims to increase production for its own Cannasticks and provide toll production to other Licensed Producers. Established in 2013, the company is a recognized leader in the cannabis industry, focusing on scientific research and product development.

THC BioMed Intl Ltd. has successfully shipped its THC Kiss Gummies to cannabis stores in British Columbia. Each package includes 4 gummies with a combined total of 10 mg of THC, using the company’s proprietary Kiss cannabis extract. Additionally, THC BioMed has enhanced its website and e-commerce platform to cater to the recreational cannabis market, with ongoing improvements. Established in 2013, the company continues to pursue leadership in the cannabis industry, focusing on beverages and edibles while conveying a strong belief in its positioning for future growth.

THC BioMed Intl Ltd. announced on Feb. 17, 2021 that Fundamental Research Corp. has updated its independent investment analysis coverage on the company, which includes a change of valuation. THC BioMed states that this update is for informational purposes only and does not endorse the content of the report. The company operates under the Cannabis Act as a licensed producer of medical and recreational cannabis, focusing on cultivation and sales across various forms of cannabis products.

THC BioMed Intl Ltd. has completed construction of three new strata units to enhance its edible and beverage production, as well as add facilities for baked goods. The company has submitted an application to Health Canada for approval to begin production in these new areas, responding to the increased demand for its edible products. As one of Canada's oldest licensed cannabis companies, THC BioMed aims to lead the beverage and edible market, leveraging its experience since receiving its first license in 2013.